Inhibition constants (Kis) were used as an estimate of the ability of various nucleoside analogues to be recognized as substrates by the deoxythymidine kinases (dTKs) of a 5-methoxymethyldeoxyuridine-resistant (MMdU r) mutant of herpes simplex virus type 1 (HSV-1) and its parent wild-type (wt). It was found that the Kis for the 5-position analogues MMdU, [E]-5-(2-bromovinyl)deoxyuridine, bromodeoxyuridine and iododeoxyuridine were increased approximately three-to fivefold, suggesting that they were poorer substrates for the MMdU r dTK than for the wt dTK. With the 2' analogues arabinosylthymine and 2' fluoro 5-methylarabinosyluracil, however, the Kis were increased to a much greater extent, 80-and 240-fold, respectively. These findings suggest that the resistance of the mutant MMdU r to these analogues may be due to a mutation(s) in the viral dTK that directly affects binding at the 2' recognition site and indirectly at the 5, while still allowing substantial activity with the natural substrate deoxythymidine.
SUMMARY Inhibition constants (Kis) were used as an estimate of the ability of various nucleoside analogues to be recognized as substrates by the deoxythymidine kinases (dTKs) of a 5-methoxymethyldeoxyuridine-resistant (MMdU r) mutant of herpes simplex virus type 1 (HSV-1) and its parent wild-type (wt). It was found that the Kis for the 5-position analogues MMdU, [E]-5-(2-bromovinyl)deoxyuridine, bromodeoxyuridine and iododeoxyuridine were increased approximately three-to fivefold, suggesting that they were poorer substrates for the MMdU r dTK than for the wt dTK. With the 2' analogues arabinosylthymine and 2' fluoro 5-methylarabinosyluracil, however, the Kis were increased to a much greater extent, 80-and 240-fold, respectively. These findings suggest that the resistance of the mutant MMdU r to these analogues may be due to a mutation(s) in the viral dTK that directly affects binding at the 2' recognition site and indirectly at the 5, while still allowing substantial activity with the natural substrate deoxythymidine.
Differences in substrate recognition by deoxythymidine kinases (dTKs) were first put forward as a basis for the anti-herpesvirus activity of a nucleoside analogue, arabinosylthymine (araT), in 1975 (Gentry & Aswell, 1975) . Subsequent work in this area has produced a large number of dTK-dependent anti-herpes drugs, but the usefulness of these may be limited by the rapid appearance of drug-resistant mutants (Veerisetty & Gentry, 1981; Field et al., 1980; Coen & Schaffer, 1980; Schnipper & Crumpacker, 1980) . Although most of such mutants examined thus far owe their resistance to a loss of the virus-specific dTK, two additional kinds have been observed. The first includes those in which the viral DNA polymerase gene expresses a mutation that confers resistance to the active form of the nucleoside analogue, the triphosphate. The second includes those in which the virus-specified dTK has a mutation that reduces the ability of the dTK to phosphorylate the analogue as compared to the normal substrate, dT. This latter kind of mutant offers the opportunity for correlating specific substitutions at various positions on the dT substrate molecule with a loss of activity of the enzyme.
The experiments reported here, using the 5-methoxymethyldeoxyuridine-resistant mutant of herpes simplex virus type i (HSV-I) MMdU~-20 (Veerisetty & Gentry, 1981 , 1983 , describe initial studies of the inhibition constants (K~s) of the mutant dTK for two types of nucleoside analogue. The first type is modified at the 5 position and includes [E]-5-(2-bromovinyl)deoxyuridine (BVdU), 5-iododeoxyuridine (IdU), 5-bromodeoxyuridine (BrdU), as well as MMdU, the compound used to select the mutant. The second type of analogue is modified at the 2' position and is represented by arabinosylthymine (araT) and 2' fluoro 5-methylarabinosyluracil (FMAU). The results suggest that the distance between the 5 and 2' positions in the nucleoside analogue may be a controlling factor in the recognition of the analogue by the HSV dTK.
The isolation of mutant MMdUr-20 from HSV-1 wild-type (wt), as well as its propagation in BHK cells have been described by Veerisetty & Gentry (1981) . For study of the viral dTK, (Veerisetty & Gentry, 1983) were resuspended in lysis buffer (0-01 M-Tris-HCI pH 7-5, 0-01 M-KCI, 1.0 m~-MgC12, 2 mM-dithiothreitol) and disrupted (3 x 30 s) by ultrasonic vibration at 10kHz in the Raytheon sonifier. The sample was then centrifuged at 100000g for 45 min at 4 °C. The supernatant was removed, its volume was measured, and ammonium sulphate was added (0.351 g/ml). The extract was stirred for 1 h at 4 °C, centrifuged at 15000g for 15 min and the resultant pellet was dissolved in 5-0 mM-Tris-HCI pH 7.5, 0.1 ~ glycerol. These preparations were considered 'partially purified' and were used for all enzyme assays. MMdU, BVdU, araT and FMAU were generously provided by Lorne Babiuk (University of Saskatchewan, Canada), Erik DeClercq (University of Leuven, Belgium), Haruhiko Machida (Yamasa Shoyu, Ltd, Japan) and Colin McClaren (Bristol-Myers, New York, U.S.A.) respectively. Other reagents were obtained from Sigma and New England Nuclear. The Michaelis-Menten constant (Kin) for dT of the MMdUr-20 enzyme was determined using [I4C]dT. Reaction velocities (20 min incubation) were determined for various dT concentrations at saturating levels of ATP and the values were plotted according to Hanes (1932) . The results (data not shown) indicate that the K m for dT of the mutant enzyme (0-35 gM) was quite similar to that of the wt (0-2 to 0.59 gM) as reported by other workers (Larder et al., 1983a, b; Cheng, 1976) .
The inhibition constant (Ki) was determined for several dT analogues modified at the 5 position (MMdU, BVdU, BrdU and IdU), and for araT and FMAU, which are modified at the 2' position. In all cases [14C]dT was the test substrate. The reaction rate was measured as a function of inhibitor concentration in the presence of at least two concentrations of [14C]dT (6.5 and 3-25 ~tM). The data are plotted according to Dixon (1953) and the g i values obtained directly from the plot. The Dixon plots for the MMdU~-20 dTK with MMdU and araT are shown in Fig.  1 and 2 , and the Kis for various nucleoside analogues are summarized in Table 1 .
The results in Table 1 indicate that the Kis for 5-substituted nucleosides were increased only three-to fivefold, while the increase was at least 80-fold for araT and 240-fold for FMAU, both 2'-substituted nucleosides. The apparent K i for araT with the mutant dTK, 580 ~M, is so large that it suggests that araT may not be a substrate (Veerisetty & Gentry, 1983) . These findings suggest a relationship between the binding sites for the parts of the molecules in the region of the 5 position and those in the region of the 2' position; it is proposed that the distance between these regions is the controlling factor, and that in the wt dTK there is room for considerable variation in distance between the two regions of the analogue as well as in the precise structure recognized at each region by the enzyme. If this be true and a mutation occurred that increased the requirement for precision in structure at the 2' recognition site (i.e. only 2'-deoxy would be recognized as appropriate by the dTK of , and if the portion of the dTK that recognized the 5 position still permitted considerable variation in structure of the 5 substituent, then a situation would arise which would be consistent with the data obtained. Because of the strict requirement at the 2' recognition site, araT and FMAU would be very poor substrates. 5-substituted deoxyuridines, however, could still be phosphorylated, but less efficiently because the fit at the 5 position recognition site would be less than optimal. This would occur because the mutation to a more precise fit at the 2' position would reduce the freedom of the analogue to make adjustments along the 2'-5 axis in order to achieve an optimal fit at the 5 position binding site of the dTK. The data could also be explained if MMdUr-20 were a double mutant, but we think that less likely.
It is of interest to compare our findings with those recently reported by Larder et al. (1983a) , who analysed the dTKs of three drug-resistant HSV-1 mutants. First, with their BVdU-resistant mutant, the greatest increases in K i of the dTK were to BVdU and the closely related iodovinyldeoxyuridine (45-and 62-fold, respectively), with substantially lower increases for the 2' analogues araT and FMAU (1.8-fold and 5.4-fold). With their mutants selected for resistance to acyclovir (ACV; which in this context may be considered a 2', 3' analogue), the increase in Ki with ACV was not great, although it was maximal with one or more of the other 2' analogues as compared with the 5 analogues. These observations tend to emphasize the uniqueness of our mutant MMdUr-20, because although it was selected for resistance to a 5-substituted analogue, by far the greatest changes in its dTK are in reduced binding to 2' analogues. This study was supported by grants RR-05386 and DE-06575 from the National Institutes of Health. It is a pleasure to acknowledge the technical assistance of N. Lawrence, L. Devine, M. Minyard and M. Meek. We also appreciate the help of Dr Kenneth Olsen with the manuscript.
